Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

TransMedics Group, Inc. (TMDX) had Revenue of $157.37M for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$157.37M
Net Income	$34.91M
Cost of Goods Sold	$60.78M
Gross Profit	$96.59M
Operating Expenses	$120.80M
Operating Income	$36.57M
Non-Operating Income/Expense	$-0.39M
Pre-Tax Income	$36.18M
Normalized Pre-Tax Income	$36.18M
Income after Taxes	$34.91M
Income from Continuous Operations	$34.91M
Consolidated Net Income/Loss	$34.91M
Normalized Income after Taxes	$34.91M
EBIT	$36.57M
EBITDA	$43.30M
Weighted-Average Shares Outstanding (Basic)	33.91M
Weighted-Average Shares Outstanding (Diluted)	40.56M
Earnings per Share (EPS) (Basic)	$1.03
Earnings per Share (EPS) (Diluted)	$0.92
Balance Sheet Financials
Current Assets	$558.13M
Property, Plant, and Equipment	$312.25M
Long-Term Assets	$332.39M
Total Assets	$890.52M
Current Liabilities	$56.62M
Long-Term Debt	$510.89M
Long-Term Liabilities	$515.80M
Total Liabilities	$572.42M
Common Equity	$318.10M
Tangible Shareholders Equity	$304.50M
Shareholders Equity	$318.10M
Common Shares Outstanding	34.04M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$88.75M
Cash Flow from Investing Activities	$-36.11M
Cash Flow from Financial Activities	$10.12M
Beginning Cash	$337.15M
End Cash	$401.07M
Increase/Decrease in Cash	$63.92M
Stock-Based Compensation	$18.33M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	9.86
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.62
Debt to Equity Ratio	1.61
Gross Margin	61.38%
Operating Margin	23.24%
EBIT Margin	23.24%
EBITDA Margin	--
Pre-Tax Profit Margin	22.99%
Profit Margin	22.18%
Free Cash Flow	$52.64M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.18
Inventory Turnover	1.56
Receiveable Turnover	1.50
Days Sales in Receivables	59.96
Return on Equity	10.97%
Return on Tangible Equity	11.46%
Return on Assets	3.92%
Return on Investments	4.21%
Book Value Per Share	$9.34
Free Cash Flow per Share	$1.30
Operating Cash Flow per Share	$2.19

Data from Zacks Investment Research, Inc.